I agree that this site is using cookies. You can find further informations here.
X
Stus, Viktor
16  results:
Search for persons X
?
1

Pembrolizumab Plus Axitinib Versus Sunitinib as First-line ..:

Plimack, Elizabeth R. ; Powles, Thomas ; Stus, Viktor...
European Urology.  84 (2023)  5 - p. 449-454 , 2023
Link: https://doi.org/10.1016/..
 
?
2

Corrigendum to "Pembrolizumab Plus Axitinib Versus Sunitini..:

Plimack, Elizabeth R. ; Powles, Thomas ; Stus, Viktor...
European Urology.  84 (2023)  5 - p. e123-e124 , 2023
Link: https://doi.org/10.1016/..
 
?
3

Corrigendum to "Pembrolizumab Plus Axitinib Versus Sunitini..:

Plimack, Elizabeth R. ; Powles, Thomas ; Stus, Viktor...
European Urology.  , 2023
Link: https://doi.org/10.1016/..
 
?
4

Health-related Quality of Life Analysis from KEYNOTE-426: P..:

Bedke, Jens ; Rini, Brian I. ; Plimack, Elizabeth R....
European Urology.  82 (2022)  4 - p. 427-439 , 2022
Link: https://doi.org/10.1016/..
 
?
5

Characteristics of the Incidence and Prevalence of Chronic ..:

Saidakova, Natalia ; Stus, Viktor ; Havva, Natalia
Health of Man.  , 2021
Link: https://doi.org/10.30841..
 
?
6

RESTORE-IMI 1: A Multicenter, Randomized, Double-blind Tria..:

Paschke, Amanda ; Butterton, Joan R ; Kartsonis, Nicholas A...
Clinical Infectious Diseases.  70 (2019)  9 - p. 1799-1808 , 2019
Link: https://doi.org/10.1093/..
 
?
7

Fosfomycin for Injection (ZTI-01) Versus Piperacillin-tazob..:

Kaye, Keith S ; Rice, Louis B ; Dane, Aaron L...
Clinical Infectious Diseases.  69 (2019)  12 - p. 2045-2056 , 2019
Link: https://doi.org/10.1093/..
 
?
8

1367. Clinical Cure in Secondary Efficacy Populations in Pa..:

Kaye, Keith ; Rice, Louis B ; Stus, Viktor...
Open Forum Infectious Diseases.  5 (2018)  suppl_1 - p. S418-S419 , 2018
Link: https://doi.org/10.1093/..
 
?
9

Intravenous Fosfomycin (ZTI-01) for the Treatment of Compli..:

Kaye, Keith S ; Rice, Louis B ; Dane, Aaron...
Open Forum Infectious Diseases.  4 (2017)  suppl_1 - p. S528-S528 , 2017
Link: https://doi.org/10.1093/..
 
?
10

Axitinib Versus Sorafenib in First-Line Metastatic Renal Ce..:

Hutson, Thomas E. ; Al-Shukri, Salman ; Stus, Viktor P....
Clinical Genitourinary Cancer.  15 (2017)  1 - p. 72-76 , 2017
Link: https://doi.org/10.1016/..
 
?
11

Characteristics of the Incidence and Prevalence of Chronic ..:

Saidakova, Natalia ; Stus, Viktor ; Havva, Natalia
http://health-man.com.ua/article/view/237525/236902.  , 2021
Link: http://health-man.com.ua..
 
?
12

Characteristics of the Incidence and Prevalence of Chronic ..:

Saidakova Natalia ; Stus Viktor ; Havva Natalia
https://zenodo.org/record/5168960.  , 2021
Link: https://zenodo.org/recor..
 
?
13

RESTORE-IMI 1: A Multicenter, Randomized, Double-blind Tria..:

Motsch, Johann ; Murta de Oliveira, Cláudia ; Stus, Viktor...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156774/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
14

1367. Clinical Cure in Secondary Efficacy Populations in Pa..:

Kaye, Keith ; Rice, Louis B ; Stus, Viktor...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252603/.  , 2018
Link: http://www.ncbi.nlm.nih...
 
?
15

Effect of Meropenem-Vaborbactam vs Piperacillin-Tazobactam ..:

Kaye, Keith S ; Bhowmick, Tanaya ; Metallidis, Symeon...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5838656/.  , 2018
Link: http://www.ncbi.nlm.nih...
 
1-15